BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9187444)

  • 1. Hodgkin's disease: complications of therapy and excess mortality.
    Hoppe RT
    Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mortality after successful treatment for Hodgkin's disease.
    Hudson MM; Poquette CA; Lee J; Greenwald CA; Shah A; Luo X; Thompson EI; Wilimas JA; Kun LE; Crist WM
    J Clin Oncol; 1998 Nov; 16(11):3592-600. PubMed ID: 9817280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
    Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
    J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancers following pediatric Hodgkin's disease.
    Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
    J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
    J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major complications and causes of death in patients treated for Hodgkin's disease.
    van Rijswijk RE; Verbeek J; Haanen C; Dekker AW; van Daal WA; van Peperzeel HA
    J Clin Oncol; 1987 Oct; 5(10):1624-33. PubMed ID: 3655860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
    Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
    J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia following Hodgkin's disease.
    Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
    N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease: summary of twenty years' experience.
    Mazza P; Bocchia M; Zinzani PL; Fiacchini M; Gherlinzoni F; Bandini G; Bendandi M; Frezza GP; Neri S; Barbieri E
    Haematologica; 1992; 77(6):487-93. PubMed ID: 1283856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cause-specific mortality of patients treated for Hodgkin's disease.
    Aleman BM; van den Belt-Dusebout AW; Klokman WJ; Van't Veer MB; Bartelink H; van Leeuwen FE
    J Clin Oncol; 2003 Sep; 21(18):3431-9. PubMed ID: 12885835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia after the treatment of Hodgkin's disease.
    Henry-Amar M; Dietrich PY
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.